TY - JOUR
T1 - The inclusion of augmented intelligence in medicine
T2 - A framework for successful implementation
AU - Bazoukis, George
AU - Hall, Jennifer
AU - Loscalzo, Joseph
AU - Antman, Elliott Marshall
AU - Fuster, Valentín
AU - Armoundas, Antonis A.
N1 - Publisher Copyright:
© 2021 The Author(s)
PY - 2022/1/18
Y1 - 2022/1/18
N2 - Artificial intelligence (AI) algorithms are being applied across a large spectrum of everyday life activities. The implementation of AI algorithms in clinical practice has been met with some skepticism and concern, mainly because of the uneasiness that stems, in part, from a lack of understanding of how AI operates, together with the role of physicians and patients in the decision-making process; uncertainties regarding the reliability of the data and the outcomes; as well as concerns regarding the transparency, accountability, liability, handling of personal data, and monitoring and system upgrades. In this viewpoint, we take these issues into consideration and offer an integrated regulatory framework to AI developers, clinicians, researchers, and regulators, aiming to facilitate the adoption of AI that rests within the FDA's pathway, in research, development, and clinical medicine.
AB - Artificial intelligence (AI) algorithms are being applied across a large spectrum of everyday life activities. The implementation of AI algorithms in clinical practice has been met with some skepticism and concern, mainly because of the uneasiness that stems, in part, from a lack of understanding of how AI operates, together with the role of physicians and patients in the decision-making process; uncertainties regarding the reliability of the data and the outcomes; as well as concerns regarding the transparency, accountability, liability, handling of personal data, and monitoring and system upgrades. In this viewpoint, we take these issues into consideration and offer an integrated regulatory framework to AI developers, clinicians, researchers, and regulators, aiming to facilitate the adoption of AI that rests within the FDA's pathway, in research, development, and clinical medicine.
UR - http://www.scopus.com/inward/record.url?scp=85122933860&partnerID=8YFLogxK
U2 - 10.1016/j.xcrm.2021.100485
DO - 10.1016/j.xcrm.2021.100485
M3 - Review article
C2 - 35106506
AN - SCOPUS:85122933860
SN - 2666-3791
VL - 3
JO - Cell Reports Medicine
JF - Cell Reports Medicine
IS - 1
M1 - 100485
ER -